S&P 500
5,932.61
-0.5%
-30.99
DJI
42,622.75
-0.4%
-169.32
NASDAQ
$19,116.72
-0.5%
-$98.74
Bitcoin
106,189.00
+1.1%
+1,155.56
AAPL
$206.37
-1.2%
-$2.41
AMZN
$203.83
-1.1%
-$2.33
GOOG
$165.38
-1.5%
-$2.49
META
$636.00
-0.7%
-$4.43
MSFT
$457.14
-0.4%
-$1.73
NVDA
$134.14
-1.1%
-$1.43
TSLA
$345.07
+0.9%
+$2.98
Vaxcyte (NASDAQ: PCVX)
$36.07
(12.6%)
$4.04
Price as of May 20, 2025, 3:35 p.m. ET
Vaxcyte Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Vaxcyte Company Info
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering, and Jeff Fairman on November 27, 2013 and is headquartered in San Carlos, CA.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.